Hengen applies lessons from brain to quantum sensing
Biologist Keith Hengen, in WashU Arts & Sciences, is applying lessons from the brain to next-generation quantum sensors through a U.S. Department of Energy-funded project.
FDA clears blood test to aid evaluation for Alzheimer’s disease
The biomarker test, called PrecivityAD2, was developed from technology invented at WashU Medicine by Randall J. Bateman, MD, and David M. Holtzman, MD.
Newly found ‘immune organ’ inside skull directs brain defense
WashU Medicine researchers discovered immune hubs in the skull bone marrow responsible for mounting a rapid immune response in the brain, which may point to new ways to fight brain cancer and neurodegenerative diseases.
Laser therapy offers weapon against deadly brain tumors
The extent of tumor clearance and timing of treatment are important factors that help improve survival, according to a large analysis of patient outcomes by researchers at WashU Medicine.
Scientists identify brain’s brake that shuts off chronic pain
A finding in mice by WashU Medicine researchers could lead to targeted treatments for chronic nerve pain.
Zipfel elected president of Society of Neurological Surgeons
Gregory Zipfel, MD, head of the Taylor Family Department of Neurosurgery at WashU Medicine, has been elected president of the Society of Neurological Surgeons. His election continues a tradition of WashU Medicine leadership of the society dating back to 1920.
Sensory overload in kids has distinct neurobiological roots
A study led by WashU Medicine researchers finds that sensory distress is directly related to both autism and anxiety, but not ADHD. The research also identified distinct patterns of brain connectivity linked to sensory sensitivity.
WashU announces new academic-industry collaboration with Bristol Myers Squibb
WashU and Bristol Myers Squibb have formed a multiyear collaboration to advance drug development projects in the neurosciences. WashU medical and research trainees will have opportunities to work alongside the company’s scientists at its facilities as part of the agreement.
Dementia rising across Latino populations, multidecade study finds
Research led by WashU Medicine neurologist Jorge Llibre-Guerra, MD, provides the first direct evidence that some parts of Latin America are moving in the opposite direction of dropping dementia rates in the U.S. and other wealthy nations.
DNA damage can trigger neurons to self-destruct
WashU Medicine researchers identified key details of how DNA damage can flip a nerve cell’s self-destruct switch. The new study could lead to novel routes to preventing neurodegeneration in a variety of diseases.
Older Stories